Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05916248
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2023-06-02
Brief Title:
Personalized Tumor Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
Sponsor:
Organization:
Ruijin Hospital